Prof. Yong Hu, Nanjing University, China
Dr. Hu Yong, Ph.D., is a renowned professor at the College of Engineering and Applied Science, Nanjing University, and a Humboldt Scholar. With a dedicated focus on the application of nanomaterials and nanotechnology in the biomedical field, his research explores the unique physicochemical properties of nanomaterials for drug delivery and tumor diagnosis and treatment. Dr. Hu has made significant contributions to his field, publishing over 100 papers in prestigious international journals such as JACS, Angewandte Chemie, Nature Communications, and Advanced Materials, with his work being cited more than 7,000 times and an H-index of 50. His groundbreaking research has earned him the First Prize Award for Natural Science Research from China’s Ministry of Education. A recognized academic leader, Dr. Hu is part of Jiangsu Province’s “333 High-level Talents Cultivation Project” and serves as a young and middle-aged academic leader under the “Qinglan Project” of the Jiangsu Provincial Department of Education. His contributions to nanotechnology and biomedical research continue to influence the development of novel therapeutic strategies and diagnostic tools.
SCOPUS
Summary:
Professor Hu Yong is a highly accomplished researcher with a distinguished record in nanotechnology applications within biomedical sciences, particularly in drug delivery and cancer treatment. His extensive academic output, reflected in over 100 high-impact publications with more than 7,000 citations and an H-index of 50, underscores the depth and influence of his work. Many of these papers have been featured in premier journals like JACS, Angewandte Chemie, Nature Communications, and Advanced Materials, solidifying his reputation within the field.
Education:
Dr. Hu earned his Ph.D. in a field related to nanotechnology or engineering, establishing a strong foundation for his future research endeavors in nanomaterials and biomedical applications. Specific details of his earlier academic degrees, such as his undergraduate and master’s studies, are not provided but are likely in related areas of engineering or materials science.
Work Experience:
Dr. Hu has held a longstanding position as a professor at Nanjing University, where he conducts pioneering research on nanomaterials for biomedical applications, including drug delivery systems and tumor diagnosis and treatment. He is recognized for his extensive publication record, with over 100 papers in top international journals like Journal of the American Chemical Society (JACS), Angewandte Chemie International Edition, Nature Communications, and Advanced Materials. His research has received over 7,000 citations, and he has an impressive H-index of 50, indicating significant impact within his field.
In recognition of his contributions, Dr. Hu received the First Prize Award for Natural Science Research from the Ministry of Education. His expertise and leadership have also been recognized through key provincial initiatives: he is a selected talent in the “333 High-level Talents Cultivation Project” and serves as a young and middle-aged academic leader under the “Qinglan Project” by the Jiangsu Provincial Department of Education.
Publication top Notes:
Photothermally reinforced chemodynamic therapy in the treatment of osteosarcoma by polydopamine-modified, copper peroxide loaded ZIF8 nanoparticles
T1/T2 Proportional Magnetic Resonance Nanoprobe Monitoring Tumor Autophagy during Chemotherapy
Epi-Endocytic Performance Engineering through Nanomaterials Co-Challenging: A Study of Mechanism and Implication in Radiotherapy
Low-dose doxorubicin loaded extracellular vesicles combined Fas/FasL pathway-mediated chemo-sensitization and immunotherapy against tumor
Ligand Phase Separation-Promoted, “Squeezing-Out” Mode Explaining the Mechanism and Implications of Neutral Nanoparticles That Escaped from Lysosomes
Design, Synthesis and Pharmacological Evaluation of Novel 4-Phenoxyquinoline Derivatives as VEGFR2 Kinase Inhibitors for Tumor Treatment
Advances in Targeting Drug Biological Carriers for Enhancing Tumor Therapy Efficacy